fig1

Extracellular vesicles as a promising biomarker resource in liquid biopsy for cancer

Figure 1. Clinical utility of liquid biopsy in cancer. Liquid biopsy presents a minimally invasive nature and thus has the potential to impact clinical practice at multiple stages of cancer management. This technique can contribute to early diagnosis, pathological condition monitoring, and tailored treatment development according to the cancer biology of individual patients. After cancer treatment, liquid biopsy can support follow-up care by providing early evidence of recurrence or therapy resistance.

Extracellular Vesicles and Circulating Nucleic Acids
ISSN 2767-6641 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/